GGrantIndex
Sort

11,323 grants matching glioblastoma

Project 1: Inhibition of Metastasis Utilizing Pharmacological Ascorbate in Pancreas Cancer

$502,555
Joseph J Cullen · University Of Iowa · P01 · FY2022 · CA

Targeted Inhibition in Leukemia

$502,537
Nicolas Nassar · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · CA

Development of Potent Estrogen Receptor Beta Agonists for Treating Glioblastoma

$502,525
Ratna K Vadlamudi · University Of Texas Hlth Science Center · R01 · FY2024 · CA

Lentiviral-MGMT gene transfer into hematopoietic stem cells

$502,085
Stanton L Gerson · Lentigen Corporation · R42 · FY2010 · CA

IDO1 and Immunotolerance in Glioblastoma

$502,054
Derek Alan Wainwright · Loyola University Chicago · R01 · FY2025 · NS

Imaging Brain Metabolism Using MRS of Hyperpolarized 13C-Pyruvate

$501,869
Daniel M Spielman · Stanford University · R01 · FY2018 · EB

Advanced Development and Validation of 3 Dimensional Spheroid Culture of Primary Cancer Cells using Nano3D Technology

$501,426
Timothy Patrick Spicer · Scripps Florida · R33 · FY2016 · CA

CDKN2A couples lipid metabolism to ferroptosis in glioblastoma

$501,221
David A. Nathanson · University Of California Los Angeles · R01 · FY2024 · NS

Development of Novel MNK Inhibitors for Treating Glioblastoma

$501,170
Leonidas C Platanias · Northwestern University At Chicago · R01 · FY2022 · NS

Development of Novel MNK Inhibitors for Treating Glioblastoma

$501,170
Leonidas C Platanias · Northwestern University At Chicago · R01 · FY2020 · NS

Development of Novel MNK Inhibitors for Treating Glioblastoma

$501,170
Leonidas C Platanias · Northwestern University At Chicago · R01 · FY2021 · NS

Development of Novel MNK Inhibitors for Treating Glioblastoma

$501,170
Leonidas C Platanias · Northwestern University At Chicago · R01 · FY2023 · NS

Mechanisms of Chemo/Radioresistance in Human Gliomas

$501,160
John J Laterra · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2011 · NS

Blood-brain barrier disruption with implantable ultrasound to enhance paclitaxel delivery: A Phase 1-2 clinical trial in recurrent glioblastoma

$501,049
Adam M Sonabend · Northwestern University At Chicago · R01 · FY2021 · CA

Mechanisms of Chemo/Radioresistance in Human Gliomas

$500,361
John J Laterra · Hugo W. Moser Res Inst Kennedy Krieger · R01 · FY2012 · NS

Targeting metabolic vulnerabilities in glioblastoma

$500,340
David A. Nathanson · University Of California Los Angeles · R01 · FY2018 · CA

Enhanced Viro-Immunotherapy for Breast Cancer Brain Metastasis

$500,175
Ji Young Yoo · University Of Texas Hlth Sci Ctr Houston · R01 · FY2023 · CA

Project 2: Molecular and Clinical Inputs Affecting Optimization of Glioma Therapy

$500,125
Eric C Holland · Dana-Farber Cancer Inst · U54 · FY2019 · CA

Validation of a novel treatment for glioblastoma using oncolytic Zika virus

$500,000
Parvez Akhtar · Up Oncolytics, Inc. · R44 · FY2024 · NS

Molecular Imaging of Resident Cardiac Stem Cells

$500,000
Joseph C Wu · Stanford University · RC1 · FY2009 · HL

SERIAL BLOCK-FACE SCANNER FOR MESO-SCALE BIOLOGICAL IMAGING

$500,000
Mark H Ellisman · University Of California, San Diego · S10 · FY2010 · RR

Phase 2/3 Study of Toca 511-Toca FC vs SOC in Recurrent GBM-AA IND 14173 9Jul2015

$500,000
Asha Das · Tocagen, Inc. · R01 · FY2017 · FD

Ph2a Study of DNX-2401 for Treatment of Glioblastoma (GBM) IND13,678 (12/23/2014)

$500,000
Frank Tufaro · Dnatrix, Inc. · R01 · FY2017 · FD

Phase 2/3 Study of Toca 511-Toca FC vs SOC in Recurrent GBM-AA IND 14173 9Jul2015

$500,000
Sophie Visonneau · Tocagen, Inc. · R01 · FY2019 · FD

Cancer as a Complex Adaptive System

$500,000
Robert A Gatenby · H. Lee Moffitt Cancer Ctr & Res Inst · U54 · FY2020 · CA